Discontinued — last reported Q3 '25
Non-Current Assets
Other Non-Current Assets
West Pharmaceutical Services Other Non-Current Assets increased by 1.5% to $81.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.8%, from $70.20M to $81.30M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Assets shows an upward trend with a 44.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ4 2021
Last reportedQ3 2025
How to read this metric
Significant fluctuations may warrant investigation into the nature of the underlying assets, such as changes in long-term investments or non-core holdings.
Detailed definition
This represents a catch-all category for long-term assets that do not fit into standard classifications like property, p...
Peer comparison
Common in most balance sheets as a residual category for non-material long-term items.
Metric ID:
other_non_current_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $16.00M | $17.00M | $16.70M | $17.10M | $17.60M | $1.20M | $38.40M | $36.70M | $600.00K | $1.40M | $21.30M | $19.00M | $50.10M | $69.30M | $74.30M | $70.20M | $70.50M | $75.80M | $80.10M | $81.30M |
| QoQ Change | — | +6.3% | -1.8% | +2.4% | +2.9% | -93.2% | >999% | -4.4% | -98.4% | +133.3% | >999% | -10.8% | +163.7% | +38.3% | +7.2% | -5.5% | +0.4% | +7.5% | +5.7% | +1.5% |
| YoY Change | — | — | — | — | +10.0% | -92.9% | +129.9% | +114.6% | -96.6% | +16.7% | -44.5% | -48.2% | >999% | >999% | +248.8% | +269.5% | +40.7% | +9.4% | +7.8% | +15.8% |
Range$600.00K – $81.30M
CAGR+40.8%
Avg YoY Growth+855.1%
Median YoY Growth+16.2%
Current Streak4 quarters growth
Other Non-Current Assets at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's other non-current assets?
- West Pharmaceutical Services (WST) reported other non-current assets of $81.30M in Q1 2026.
- How has West Pharmaceutical Services's other non-current assets changed year-over-year?
- West Pharmaceutical Services's other non-current assets increased by 15.8% year-over-year, from $70.20M to $81.30M.
- What is the long-term trend for West Pharmaceutical Services's other non-current assets?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's other non-current assets has grown at a 44.1% compound annual growth rate (CAGR), from $12.90M to $80.10M.
- What does other non-current assets mean?
- Miscellaneous long-term assets that do not fall into major categories like property or investments.